Geographic Distribution of Patients in Washington State’s Medication Assisted Treatment – Prescription Drug and Opioid Addiction Project

Opioid use disorder (OUD) continues to be a public health emergency that is receiving increased attention through legislative action. One such action, the Medication Assisted Treatment – Prescription Drug and Opioid Addiction (MAT-PDOA) program, is a three year, federally funded initiative to increase access to MAT and was awarded to Washington State’s Department of Social and Health Services in August 2015. With this funding, Washington was able to expand access to MAT with buprenorphine in three office based setting. Some patients, however, travel lengthy distances to receive MAT with buprenorphine for OUD. This report describes the geographic distribution of patients treated for OUD by the Washington State MAT-PDOA clinical sites in the first two years of funding.